Table of contents

ABN Abstracts

• 001: STROKE RISK AFTER A FIRST LATE–ONSET MIGRAINE–LIKE TRANSIENT NEUROLOGICAL ATTACK (TNA): OXFORD VASCULAR STUDY TNA COHORT (9 October, 2013)

  Maria Assuncao Tuna, Ziyha Mehta, Peter M Rothwell
• 002: INCIDENCE, OUTCOME AND FUTURE PROJECTIONS OF ATRIAL FIBRILLATION–RELATED STROKE AND SYSTEMIC EMBOLISM AT AGE ≥80 YEARS: 10–YEAR RESULTS OF A POPULATION–BASED STUDY (9 October, 2013)

  Gabriel SC Yiin, Dominic PJ Howard, Nicola LM Paul, Ziyah Mehta, Peter M Rothwell
• 003: IDENTIFICATION OF MISSED HYPERTENSION AND HYPERTENSIVE ARTERIOPATHY WITH HOME VERSUS AMBULATORY BLOOD PRESSURE MEASUREMENT IN PATIENTS WITH TIA OR MINOR STROKE (9 October, 2013)

  Alastair Webb, Linxin Li, Michela Simoni, Michelle Wilson, Nicola Paul, Lionel Tarassenko, Peter Rothwell
• 004: CONTRASTING IMPACT OF FAST–TEST PUBLIC EDUCATION ON BEHAVIOUR AFTER TIA AND MINOR STROKE VERSUS MAJOR STROKE: A POPULATION–BASED STUDY (9 October, 2013)

  Frank J Wolters, Nicola LM Paul, Arvind Chandratheva, Linxin Li, Peter M Rothwell
• 005: LONG TERM RISK OF STROKE VERSUS ACUTE CORONARY EVENTS AFTER TIA AND STROKE: A POPULATION–BASED STUDY (9 October, 2013)

  Nicola LM Paul, Ziyah Mehta, Louise Silver, Olivia C Geraghty, Peter M Rothwell
• 006: LARGE CT PERFUSION–DEFINED MISMATCH PREDICTS EARLY IMPROVEMENT AFTER IV THROMBOLYSIS IN ACUTE ISCHAEMIC STROKE (9 October, 2013)

  Patrick D Collins, Krishna A Dani, Fiona Moreton, Xuya Huang, Niall JJ MacDougall, Ferghal McVerry, Mary Joan Macleod, Joanna M Wardlaw, Keith W Muir
• 007: EMERGENCY NEUROMUSCULAR ADMISSIONS ARE AVOIDABLE: A REGIONAL AUDIT OF UNPLANNED HOSPITAL ADMISSIONS OF NEUROMUSCULAR PATIENTS 2009–2011: FINAL RESULTS AND RECOMMENDATIONS (9 October, 2013)

  Fatima Jaffer, Mary M Reilly, Ros Quinlivan, Francesco Muntoni, Christopher Turner, Matthew Parton, Michael Lunn, David Hilton–Jones, Marilena Korkodilos, Michael G Hanna
• 008: ACUTE BACTERIAL MENINGITIS MANAGEMENT IN ADULTS IS INADEQUATE: A MULTI–CENTRE AUDIT AND SURVEY (9 October, 2013)

  Edward J Needham, J William Brown, Dhaneesha NS Senaratne, A Mariam Karimi, Thomas A Gibson, Emily E Brown, Sooha Kim, John W Thorpe, Adrian Boyle, Alasdair J Coles
• 009: A NOVEL INTERNET–BASED METHOD OF CAPTURING OUTCOMES IN MULTIPLE SCLEROSIS (9 October, 2013)

  Sara Leddy, Shahrzad Hadavi, Andrew Mc Carren, Gavin Giovanonni, Ruth Dobson
• 010: ARE NEUROLOGY TRAINEES ADEQUATELY SUPERVISED WHEN SEEING IN–PATIENT WARD REFERRALS? (9 October, 2013)

  Mahinda Yogarajah, Mariyam Mirfenderesky, Tazeen Ahmed, Fred Schon
• 011: A SURVEY OF UNDERGRADUATE TEACHING OF CLINICAL NEUROLOGY IN THE UNITED KINGDOM 2012 (9 October, 2013)

  Kanchan Sharma, Dilan Athauda, Emily Robbins
• 012: BRITISH NEUROLOGICAL SURVEILLANCE UNIT (9 October, 2013)

  Rustam Al–Shahi Salman
• 013: PARKIN DISEASE–A CLINICOPATHOLOGICAL ENTITY? (9 October, 2013)

  Karen M Doherty, Laura Silveira – Moriyama, Laura Parkkinen, Daniel G Healy, Michael Farrell, Niccolo E Mencacci, Zeshan Ahmed, Francesca M Brett, John Hardy, Niall Quinn, Timothy J Counihan, Timothy Lynch, Zoe V Fox, Tamas Revesz, Andrew J Lees, Janice L Holton
• 014: LEVODOPA–INDUCED MOTOR COMPLICATIONS IN AN INCIDENT PARKINSON'S DISEASE COHORT (9 October, 2013)

  Nicholas W Scott, Angus D Macleod, Carl E Counsell
• 015: CIGARETTE SMOKING, ALCOHOL CONSUMPTION AND CAFFEINE INTAKE IN PD AND PD SUBTYPES: A COMMUNITY–BASED, INCIDENT COHORT WITH MATCHED CONTROLS (9 October, 2013)

  Angus D Macleod, Carl E Counsell
• 016: TIGARB CAUSES MITOCHONDRIAL DYSFUNCTION AND NEURONAL LOSS IN PINK1 DEFICIENCY (9 October, 2013)

  Oliver Bandmann
• 017: VARIANT CJD PRESENTS DIFFERENTLY IN OLDER PATIENTS (9 October, 2013)

  Graham Mackay, Richard Knight, Robert Will
• 018: UNRAVELLING THE MYSTERIES OF SPORADIC CJD (9 October, 2013)

  Graham Mackay, Helen Yull, James Ironside, Mark Head, Richard Knight
• 019: THE MANAGEMENT OF REFRACTORY STATUS EPILEPTICUS IN ADULTS IN THE UK: NO CONSISTENCY IN PRACTICE SO TIME FOR A CHANGE? (9 October, 2013)

  Mitesh Patel
• 020: THE ROLE OF BRAIN MRI IN THE DIAGNOSIS OF NEUROMYELITIS OPTICA (9 October, 2013)

  Sebastian Luppe, Hannah Khirwadkar, Valentina Tomassini, Margaret Hourihan, Neil Robertson
• 021: CSF ANALYSIS AND THE DIAGNOSIS OF NEUROMYELITIS OPTICA (9 October, 2013)

  Sebastian Luppe, Neil Robertson
• 022: ELEVATED CREATINE KINASE SUGGESTS BETTER PROGNOSIS IN PATIENTS WITH AMYOTROPHIC LATERAL SCLEROSIS (9 October, 2013)

  Muhammad Rafiq, Ellen Lee, Michael Bradburn, Christopher McDermott, Pamela Shaw
• 023: RESTING FUNCTIONAL CONNECTIVITY REVEALS RESIDUAL FUNCTIONAL ACTIVITY IN ALZHEIMER'S DISEASE (9 October, 2013)

  Giovanna Zamboni, Gordon Wilcock, Gwenaelle Douaud, Erin Drazich, Ellen McCulloch, Nicola Filippini, Irene Tracey, Jonathan Brooks, Steve Smith, Clare Mackay
• 024: A CASE OF THE BLACK SPOT (9 October, 2013)

  Kanchan Sharma, Paul Craig, Eduardo Calonje, Nikki Cohen, James Milne, Geraint Fuller
• 025: AUTOLOGOUS MESENCHYMAL STEM CELLS FOR THE TREATMENT OF SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS: AN OPEN–LABEL PHASE 2A PROOF–OF–CONCEPT STUDY (9 October, 2013)

  Peter Connick, Siddharthan Chandran
• 026: LATE–ONSET MULTIPLE SCLEROSIS IN SOUTH–EAST WALES (9 October, 2013)

  Katharine Harding, Megan Griffiths, Mark Wardle, Valentina Tomassini, Trevor Pickersgill, Neil Robertson
• 027: CHANGING FACE OF MULTIPLE SCLEROSIS IN THE UNITED KINGDOM 1990–2010. AN INCIDENCE AND PREVALENCE STUDY (9 October, 2013)

  Isla S Mackenzie, Steven V Morant, Glenys A Bloomfield, Thomas M MacDonald, Jonathan I O'Riordan
• 028: THERAPY RELATED ACUTE LEUKAEMIA WITH MITOXANTRONE: 4 YEARS ON, WHAT IS THE RISK AND CAN IT BE LIMITED? (9 October, 2013)

  Richard James Ellis, Sean Brown, Mike Boggild
• 029: SODIUM ACCUMULATION IS ASSOCIATED WITH DISABILITY AND PROGRESSION IN MULTIPLE SCLEROSIS: A 23NA MRI STUDY (9 October, 2013)

  David Paling, Bhavana Solanky, Frank Riemer, Daniel Tozer, Claudia Wheeler–Kingshott, Raju Kapoor, Xavier Golay, David Miller
• 030: EPISTATIC EFFECTS ON THE PHENOTYPE OF MULTIPLE SCLEROSIS (9 October, 2013)

  Katharine Harding, Samantha Loveless, Mark Wardle, Valentina Tomassini, Trevor Pickersgill, Neil Robertson
• 031: TOWARDS AN ENDOPHENOTYPE IN MULTIPLE SCLEROSIS (9 October, 2013)

  Ruth Dobson, Joanne Topping, Sreeram Ramagopalan, Gavin Giovannoni
• 032: MALFORMATION RISKS OF ANTIEPILEPTIC DRUG MONOTHERAPIES IN PREGNANCY (9 October, 2013)

  Ellen Campbell, Fiona Kennedy, Beth Irwin, Patrick Morrison, Norman Delanty, Stephen Hunt, John Craig, Jim Morrow
• 033: READING BETWEEN THE LINES: A CASE SERIES IN PRIMARY READING EPILEPSY (9 October, 2013)

  Roisin Lonergan, Alan McCarthy, ASM Shamsu, Jill Byrne, Aine Merwick, Richard Reilly, Tim Lynch, Christopher McGuigan, Sean Connolly
• 034: A CHEMICAL–GENETICS APPROACH TO STUDY THE MOLECULAR PATHOLOGY OF CENTRAL SEROTONIN ABNORMALITIES IN FETAL VALPROATE SYNDROME (9 October, 2013)

  John Jacob, Ribes Vanessa, Moore Steve, Constable Sean, Wilkinson David, Briscoe James
• 035: LAMBERT EATON MYASTHENIC SYNDROME ANTIBODIES DECREASE SYNAPTIC VESICLE EXOCYTOSIS IN NEURONAL CULTURES (9 October, 2013)

  Jennifer Spillane, YE Ermolyuk, KE Volynski, DM Kullmann
• 036: AUTOANTIBODIES IN GLIOMA PATIENTS: IMMUNE BIOMARKERS FOR IDENTIFICATION OF LOW GRADE TUMOURS (9 October, 2013)

  James Coleman, Saam Sedehizadeh, Caroline Chapman, Rachelle Shafei, Alison Thorpe, John Robertson, Paul Maddison
• 037: AUTOIMMUNE ENCEPHALITIS SCREEN–A REVIEW OF RAPID DIAGNOSTIC SCREENING IN 600 PATIENTS OVER 5 YEARS (9 October, 2013)

  Girija Sadalage, Abid Karim, Saiju Jacob
• 038: A RETT-LOOK-ALIKE WITH BRAIN IRON ACCUMULATION (9 October, 2013)

  Sarah Crisp, Esther Meyer, Allison Gregory, Hayley Archer, Susan Hayflick, Manju A Kurian, Rajith de Silva
• 039: UNNOTICED IN CHILDHOOD, DISABLING IN ADULTHOOD: A PROGRESSIVE BUT TREATABLE DISEASE… (9 October, 2013)

  Sheena Murdoch, Amy Davidson, Peter Galloway, Robin Joseph, Johann Selvarajah
• 040: RASH DECISIONS–DERMATOLOGICAL MANIFESTATIONS PRECEDING A PROGRESSIVE NEUROLOGICAL SYNDROME (9 October, 2013)

  Gary Doherty, Angela Vincent, Amanda Cox
• 041: TRIPPED UP BY AN UNUSUAL DIAGNOSIS? (9 October, 2013)

  WO Pickrell, D Sudarshi, V Eligar, M Brown, RJ Walters
• 042: JUST A GRAZE? (9 October, 2013)

  Anisha Doshi, Dima Dahdalleh, Clare Warrell, Dimitri Kullmann
• 043: FEVER AND CONFUSION IN A RETURNING SOLDIER (9 October, 2013)

  Arvind Chandratheva, Anil Ramlackhan Singh, Steve Sturman, Sridhar Chaganti, Saiju Jacob
• 044: THE TOS STUDY CONTROL DATA: HOW WELL DO NEUROLOGY IN–PATIENTS RECALL BEING EXAMINED AND DOES IT MATTER? (9 October, 2013)

  Adam Mulla, Jason Appleton, David Nicholl
• 045: SUBARACHNOID HAEMORRHAGE EXCLUSION ON THE MEDICAL ASSESSMENT UNIT; A 2 CYCLE AUDIT (9 October, 2013)

  Taymoor Asghar, Matthew Wilson, Andrew Dagens, Craig Harrow
• 046: SETTING THE STANDARDS: AUDITING MANAGEMENT OF FIRST SEIZURE IN THE EMERGENCY DEPARTMENT OF A UK TEACHING CENTRE (9 October, 2013)

  Sophie Binks, Maria Finn, Julia Aram
• 047: RESOURCE USE AND QUALITY OF CARE IN AN URBAN STROKE UNIT (9 October, 2013)

  Jennifer Boyle, Helen Casey, Claire Doyle, Matthew Walters
• 048: THE BURDEN OF NEUROLOGICAL DISEASE IN THE ACUTE INPATIENT HIV POPULATION; AN AUDIT OF 73 CONSECUTIVE ADMISSIONS (9 October, 2013)

  Rachel Brown, Mark Nelson, Angus Kennedy, John Janssen, Nicholas WS Davies
• 049: AUDIT ON INTRAVENOUS IMMUNOGLOBULIN (IVIG) USE IN ABERDEEN ROYAL INFIRMARY NEUROLOGY DEPARTMENT ACCORDING TO 2005 ASSOCIATION OF BRITISH NEUROLOGISTS (ABN) GUIDELINES (9 October, 2013)

  Bharath Kumar Cheripelli, Elizabeth Visser, Margaret–Ann Macleod
• 050: CSF CYTOLOGY QUALITY IMPROVEMENT PROJECT (9 October, 2013)

  Samer Dahdaleh, Alice Booker, Mimi Hou, Miguel A Perez–Machado
• 051: INITIAL NEUROLOGICAL ASSESSMENT: A PILOT STUDY OF THE ‘GLASGOW NEUROSCREEN’ (9 October, 2013)

  Fiona Robertson, Krishna A Dani, Edward Newman, John Paul Leach
• 052: QUALITY IMPROVEMENT PROJECT: DETECTING, INSTIGATING AND ASSESSING EFFECTIVE HANDOVER TECHNIQUES (9 October, 2013)

  Clare Warrell, Anisha Doshi, Joseph Mayhew, Eve Thacker, Peter McColgan, Timothy Yates, Jonathan Rohrer, Gordon Ingle
• 053: A PROSPECTIVE SURVEY OF AVAILABILITY OF NEUROLOGICAL EQUIPMENT IN CLINICAL AREAS IN A DISTRICT GENERAL HOSPITAL (9 October, 2013)

  Richard James Ellis, Claudia Porteous, Brendan M Davies
• 054: THE CHANGING FACE OF URGENT NEUROLOGY OUTPATIENT REFERRALS (9 October, 2013)

  Barnaby Fiddes, Robert Adam, Alastair Donaghy, Adam Whyte, Chris Allen
• 055: THE VALUE OF EEG IN THE INVESTIGATION OF UNEXPLAINED SYNCOPE IN A GENERAL HOSPITAL POPULATION (9 October, 2013)

  Pamela Pillai Velasamy, John Murray, Allan Kermode, Athanasios Gaitatzis
• 056: MEDICALLY UNEXPLAINED NEUROLOGICAL SYMPTOMS ON AN ACUTE NEUROLOGY WARD: HEALTHCARE RESOURCE UTILISATION (9 October, 2013)

  Paul Gallagher, Steven Meldrum, Susan Copstick, Adam Burnel, Audrey Matthews, Melanie Brown, Susan Walker, Pushkar Shah, Saif Razvi
• 057: THE JOY OF TEXT; INTERACTIVE LECTURES IN THE ELECTRONIC AGE (9 October, 2013)

  Jack Leach, Rebecca Morrison, Edward Newman, Krishna Dani, John Paul Leach
• 058: CRITICAL LONGITUDINAL ANALYSIS OF NEUROIMAGING REPORTS FROM GENERAL RADIOLOGISTS (THE CLANGER STUDY) (9 October, 2013)

  Mark McCarron
• 059: AN AUDIT OF INPATIENT PARKINSON'S DISEASE MANAGEMENT AT BARNET AND CHASE FARM HOSPITALS (9 October, 2013)

  Sathiji Nageshwaran, Mimi Hou, Ayesha Ejaz, Sebastian Toescu, Christos Proukakis
• 060: SETTING UP A SERVICE FOR PEOPLE WITH FUNCTIONAL DISORDERS IN A GENERAL HOSPITAL SETTING (9 October, 2013)

  Christine Sparkes, Carmel Jordan, Andrew Graham, Clare Galton, Max Damien, Petr Pokorny, Hadi Manji
• 061: AUDIT OF HEADACHE REFERRALS FROM PRIMARY CARE TO A REGIONAL HEADACHE SERVICE (9 October, 2013)

  Stefanie Zhao Lin Lip, Sarah Louise Miller, Alok Tyagi
• 062: A SURVEY OF ADVICE ON DRIVING IN NEUROLOGICAL CONDITIONS AMONGST NEUROLOGISTS AND NEUROSURGEONS (9 October, 2013)

  Siew Lee Wong, Basil Sharrack
• 063: BNSU SURVEILLANCE PROJECT: CONGENITAL CRANIAL DYSINNERVATION DISORDERS (9 October, 2013)

  Nick Gutowski
• 064: NEUROLOGICAL MANIFESTATIONS OF INFLUENZA INFECTION IN ADULTS AND CHILDREN: RESULTS OF A NATIONAL BRITISH SURVEILLANCE STUDY (9 October, 2013)

  Anu Goenka, Benedict Michael, Elizabeth Ledger, Ian Hart, Michael Absoud, Gabriel Chow, James Lilleker, Ming Lim, Michael Lunn, Deirdre Peake, Karen Pysden, Mark Roberts, Enitan Carrol, Shivaram Avula, Tom Solomon, Rachel Kneen
• 065: BNSU SURVEILLANCE PROJECT: MYOCLONUS DYSTONIA SYNDROME (9 October, 2013)

  Huw Morris
• 066: TRANSIENT EPILEPTIC AMNESIA: THE CONTRIBUTION OF THE BRITISH NEUROLOGICAL SURVEILLANCE UNIT (9 October, 2013)

  Adam Zeman, Bethan Dewar, Chris Butler
• 067: DEMYELINATION COMPLICATING ANTI–TNF THERAPY IN INFLAMMATORY BOWEL DISEASE (IBD) AND OTHER INFLAMMATORY DISORDERS (PRED4–UKCRN 11988) (9 October, 2013)

  Tariq Ahmad
• 068: LONGITUDINAL RESEARCH INTO ALZHEIMER'S DISEASE, FRONTO–TEMPORAL DEMENTIA AND OTHER DEMENTIAS (9 October, 2013)

  Martin Rossor, Rebecca Ahmed, Yuying Liang, Jane Douglas, Colin Mahoney, Jason Warren, Jonathan Schott, Nick Fox
• 069: THE MEDICAL RESEARCH COUNCIL NEUROMUSCULAR CENTRE FOR TRANSLATIONAL RESEARCH MITOCHONDRIAL DISEASE PATIENT COHORT STUDY UK: FROM CONCEPTUALISATION TO UTILISATION (9 October, 2013)

  Victoria Nesbitt, Robert Pitceathly, Simon Cockell, Joanna Poulton, Shamima Rahman, Michael Hanna, Robert Taylor, Patrick Chinnery, Douglass Turnbull, Robert McFarland
• 070: SEVERE HYPERSENSITIVITY TO ANTIEPILEPTIC DRUGS: BRITISH NEUROLOGICAL SURVEILLANCE UNIT (BNSU) (9 October, 2013)

  Vincent Yip, S Heslop, C Pennington, J Evely, AG Marson
• 071: LAMBERT–EATON MYASTHENIC SYNDROME–RESULTS FROM THE BNSU SURVEY (9 October, 2013)

  Paul Maddison, Paul Gozzard
• 072: ASSOCIATION OF OBSTRUCTIVE SLEEP APNOEA (OSA) WITH INCIDENT STROKE: A SYSTEMATIC REVIEW AND META–ANALYSIS (9 October, 2013)

  J William L Brown, Yoon Loke, Chun Shing Kwok, Alagaratnam Niruban, Phyo Myint
• 073: CT PERFUSION IN ACUTE ISCHAEMIC STROKE: DO WE COVER THE LESION AND WHAT DOES IT MEAN? (9 October, 2013)

  Patrick Collins, Krishna Dani, Fiona Moreton, Ferghal McVerry, Niall MacDougall, Mary Joan Macleod, Joanna Wardlaw, Keith Muir
• 074: STARRY NIGHTS: COMA DUE TO CEREBRAL FAT EMBOLISM SYNDROME (9 October, 2013)

  Pablo Garcia Reitboeck, Peter Jenkins, Anthony Pereira, Damian Wren
• 075: DIFFUSION MR CORRELATES OF MOTOR FUNCTION RECOVERY AFTER STROKE: A SYSTEMATIC REVIEW (9 October, 2013)

  Dheeraj Kalladka, Keith Muir
• 076: THE HALIFAX ACUTE STROKE IMAGING STUDY (HASIS): DOES CT PERFUSION SCANNING IN ACUTE ISCHEMIC STROKE PREDICT FINAL INFARCT VOLUME? (9 October, 2013)

  Gavin Langlands, Jai Shankar, Wendy Simpkin, Christine Christian, Stephen Phillips
• 077: DILATIVE VASCULOPATHY AND CEREBRAL HAEMORRHAGE AS A PRESENTATION OF LATE–ONSET POMPE DISEASE (9 October, 2013)

  James Lilleker, Mark Roberts, Bernard Boothman
• 078: REVERSIBLE LEUKOENCEPHALOPATHY AS A PRESENTATION OF CEREBRAL AMYLOID ANGIOPATHY (9 October, 2013)

  James Lilleker, J Vassallo, M Punter
• 079: SENSITIVITY OF TRANSCRANIAL DOPPLER AND TRANSOESOPHAGEAL ECHOCARDIOGRAPHY FOR THE DETECTION OF PATENT FORAMEN OVALE IN CRYPTOGENIC STROKE (9 October, 2013)

  Dania Morhij, Krishna Dani, W Stewart Hillis, Keith Muir
• 080: UNUSUAL COMPLICATION OF VERTEBRAL ARTERIAL DISSECTION (9 October, 2013)

  Senthilkumar Shanmugam, Patrick Pullicino, Gustav Strandvik
• 081: NEWLY DETECTED PAROXYSMAL ATRIAL FIBRILLATION AFTER TIA AND ISCHAEMIC STROKE ON CARDIAC MONITORING: SYSTEMATIC REVIEW AND META–ANALYSIS IN RELATION TO DURATION OF RECORDING (9 October, 2013)

  Gabriel SC Yiin, Nicola G Lovett, Peter M Rothwell
• 082: ‘THE MIND IS ITS OWN PLACE’: AMELIORATION OF CLAUSTROPHOBIA IN A PATIENT WITH SEMANTIC DEMENTIA (9 October, 2013)

  Camilla Clarke, P Fletcher, A Cifelli, JD Warren
• 083: HEAD TURNING SIGN FOR DIAGNOSIS OF DEMENTIA AND MILD COGNITIVE IMPAIRMENT: A REVALIDATION (9 October, 2013)

  Mona Ghadiri–Sani, AJ Larner
• 084: A POSITRON EMISSION TOMOGRAPHY STUDY OF [18F]–FLORBETAPIR IN ALZHEIMER'S DISEASE AND FRONTOTEMPORAL DEMENTIA (9 October, 2013)

  Christopher Kobylecki, Tobias Langheinrich, Rainer Hinz, Emma RLC Vardy, Maria–Elena Martino, Anna MT Richardson, Julie S Snowden, Jose Anton–Rodriguez, David Neary, David M Mann, Alex Gerhard, Karl Herholz
• 085: PICK ‘N’ MIX: NEUROPATHOLOGICAL DETECTION OF PERI–TUMOUR TAUOPATHY (9 October, 2013)

  Roisin Lonergan, Fiona Carthy, Michael Alexander, Kinley Roberts, Michael Farrell, Timothy Lynch
• 086: THE EVOLUTION OF FRONTOTEMPORAL DEMENTIA DUE TO THE MAPT MUTATION: A SEVENTEEN YEAR NATURAL HISTORY STUDY (9 October, 2013)

  Colin Mahoney, T Yeatman, JD Rohrer, E Manning, KK Leung, MN Rossor, JD Warren, N Fox
• 087: SYSTEMATIC REVIEW OF BIOMARKERS FOR DISEASE PROGRESSION IN ALZHEIMER'S DISEASE (9 October, 2013)

  David McGhee, Carl Counsell
• 088: SYSTEMATIC REVIEW OF THE DIAGNOSTIC UTILITY OF SPECT IMAGING IN DEMENTIA (9 October, 2013)

  Jing Ming Yeo, Xuxin Lim, Zubair Khan, Suvankar Pal
• 089: CODEX (COGNITIVE DISORDERS EXAMINATION) FOR THE DETECTION OF DEMENTIA AND MILD COGNITIVE IMPAIRMENT: DIAGNOSTIC UTILITY (9 October, 2013)

  B Ziso, AJ Larner
• 090: UNVERRICHT LUNDBORG DISEASE ASSOCIATED WITH SENSORINEURAL DEAFNESS IN A PATIENT OF INDIAN ORIGIN (9 October, 2013)

  Nadeem Akhtar, Salah Omer
• 091: RECRUITMENT PATTERN TO THE UK EPILEPSY AND PREGNANCY REGISTER (9 October, 2013)

  Ellen Campbell, Aline Russell, WH Smithson, Linda Parsons, Beth Irwin, Patrick Morrison, Stephen Hunt, John Craig, Jim Morrow
• 092: DESIGN OF THE EPOS STUDY: AN OPEN-LABEL, MULTICENTRE, NON-INTERVENTIONAL STUDY TO EVALUATE ESLICARBAZEPINE ACETATE AS ADJUNCTIVE TREATMENT TO ONE BASELINE ANTIEPILEPTIC DRUG IN ADULTS WITH PARTIAL-ONSET SEIZURES (9 October, 2013)

  M Holtkamp, C Lawthom, I Chouette
• 093: IMPROVEMENT IN QUALITY-OF-LIFE AND DEPRESSIVE SYMPTOMS DURING LONG-TERM TREATMENT WITH ESLICARBAZEPINE ACETATE: BIA-2093-301 STUDY (9 October, 2013)

  Joyce Cramer, C Elger, P Halasz, D Hodoba, A Czlonkowska, Joana Maia, L Almeida, P Soares-da-Silva
• 094: TOLERABILITY AND SAFETY OF ZONISAMIDE IN ELDERLY PATIENTS WITH PARTIAL EPILEPSY: RESULTS OF A POOLED ANALYSIS (9 October, 2013)

  E Trinka, J Segieth, L Giorgi
• 095: ALTERATIONS IN STRUCTURAL AND HAEMODYNAMIC CEREBROVASCULAR MEASURES IN LATE ONSET EPILEPSY (9 October, 2013)

  Martha Hanby, Sam Fairclough, Fadiyah Makin, Sarah Al–Bachari, Rishma Vidyasagar, Laura Parkes, Hedley Emsley
• 096: HYPEREXCITABLE BRAIN AND REFRACTORY COELIAC DISEASE: A NEW SYNDROME (9 October, 2013)

  Marios Hadjivassiliou, Jayne Fotheringham, David Sanders, Richard Grunewald, Nigel Hoggard, Ptolemy Sarrigiannis
• 097: A CASE OF MISTAKEN IDENTITY: ‘MASK PHENOMENON’ FOLLOWING A GENERALISED TONIC–CLONIC SEIZURE (GTCS) (9 October, 2013)

  Natasha Harper, Tina Ramnani, Tatiana Mihalova
• 098: BONE DISEASE IN EPILEPSY: THE FORGOTTEN SIDE EFFECT (9 October, 2013)

  Robert Hurford, Rajiv Mohanraj
• 099: WORK, REST AND PLAY; THE CLINICAL SPECTRUM OF NON–CONVULSIVE STATUS EPILEPTICUS (9 October, 2013)

  Ann Johnston, Malisa Pierri, Zed Ahmed, Khalid Hamandi
• 100: SUDDEN UNEXPECTED DEATH IN EPILEPSY INFORMATION PROVISION TO PARENTS OF CHILDREN WITH EPILEPSY–A SERVICE EVALUATION (9 October, 2013)

  Lliwen Jones, Johann Te Water Naude
• 101: COMPLICATIONS OF THE SUDEP (SUDDEN UNEXPECTED DEATH IN EPILEPSY) DISCUSSION (9 October, 2013)

  Yi Shiau Ng, Richard Davenport, Susan Duncan, Christopher Derry
• 102: NOCTURNAL SEIZURES ONLY POST TEMPORAL LOBECTOMY: CHARACTERISTICS OF AN UNUSUAL OUTCOME GROUP (9 October, 2013)

  Shanika Samarasekera, Anne McIntosh, Samuel Berkovic
• 103: PHENYTOIN AND CEREBELLAR ATAXIA: NOT ALL DOWN TO TOXICITY? (9 October, 2013)

  Priya Shanmugarajah, Nigel Hoggard, Stephen Howell, Gary Dennis, Markus Reuber, Richard Grunewald, Marios Hadjivassiliou
• 104: ROBOTIC STEREO EEG IN EPILEPSY SURGERY ASSESSMENT (9 October, 2013)

  Katarzyna Sieradzan, David Sandeman, Shelagh Smith, Kathy Trippick, Claire Johnson
• 105: CROSSED CEREBELLAR DIASCHISIS: A RADIOLOGICAL FINDING IN STATUS EPILEPTICUS NOT TO MISS (9 October, 2013)

  Syed Zaidi
• 106: COMPARISON OF ZONISAMIDE AND CARBAMAZEPINE MONOTHERAPY IN ADULTS WITH NEWLY DIAGNOSED PARTIAL EPILEPSY: PRELIMINARY RESULTS OF A PHASE III, RANDOMISED, DOUBLE-BLIND, NON-INFERIORITY TRIAL (9 October, 2013)

  Michel Baulac, Martin Brodie
• 107: GAMMA KNIFE RADIOSURGICAL TREATMENT OF MOTOR CORTEX EPILEPSY (9 October, 2013)

  Aileen McGonigal, Fabrice Bartolomei, M Gavaret, Patrick Chauvel, Jean Régis
• 108: RELEVANCE OF GAD ANTIBODIES IN ADULTS WITH EPILEPSY: EXPERIENCE IN A TERTIARY CLINIC (9 October, 2013)

  James Lilleker, Viveka Biswas, Rajiv Mohanraj
• 109: JOSEPH BABINSKI, BEYOND THE TOE SIGN–A TRIBUTE (9 October, 2013)

  Nadeem Akhtar
• 110: SPONTANEOUS INTRACRANIAL HYPOTENSION: CLINICAL FEATURES IN EIGHT CASES (9 October, 2013)

  Joseph Anderson, Robin Corkill
• 111: ‘HIS WALKING ISN'T RIGHT DOCTOR’: A CASE OF HYDROCEPHALUS PRESENTING AS AN ABNORMAL GAIT (9 October, 2013)

  John Baker
• 112: A CASE OF ‘PING–PONG’ GAZE OF UNKNOWN CAUSE (9 October, 2013)

  Jonathan Bedford
• 113: A RARE CAUSE OF HEADACHE–THE IMPORTANCE OF A TISSUE DIAGNOSIS AND PERSEVERANCE (9 October, 2013)

  Helen Defty, Anna Cavazza, Graham Warner
• 114: STARING YOU IN THE FACE! STURGE–WEBER SYNDROME IS A SPECTRUM DISORDER AND LATE PRESENTATION IS POSSIBLE (9 October, 2013)

  Jeremy Cosgrove, Ahamad Hassan
• 115: SUSAC'S SYNDROME: LIMITATIONS OF CLASSICAL TRIAD AND FUNDOSCOPY IN DIAGNOSIS. WHAT CAN WE LEARN FROM THE TABLOID LITERATURE? (9 October, 2013)

  Krishna Dani, Rachel Thomas
• 116: AN UNUSUAL BUMP ON THE HEAD: INTRAEXTRACRANIAL MENINGIOMA PRESENTING INCIDENTALLY (9 October, 2013)

  Anisha Doshi, Jamie Goddin, Dina Luder, Vivek Nadarajan
• 117: ORBITAL APEX SYNDROME AS THE PRESENTING FEATURE OF LARGE VESSEL VASCULITIS (9 October, 2013)

  Venkat Garikipati, Martin Prevett
• 118: INTRACRANIAL ARTERIOVENOUS MALFORMATION PRESENTING WITH PAPILLOEDEMA (9 October, 2013)

  Tom Hayton, Peter Gan, Girija Sadalage, Michael Burdon
• 119: SUPERFICIAL SIDEROSIS OF THE CENTRAL NERVOUS SYSTEM: A CLINICAL SERVICE REVIEW (9 October, 2013)

  Sarah Whitehorn, Rajiv Mohanraj, Matthew Jones
• 120: POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME SECONDARY TO PERITONITIS (9 October, 2013)

  Odai Jumma
• 121: PATIENTS' EXPERIENCES WITH SPINAL CORD STIMULATION FOR LUMBAR SPONDYLOTIC PAIN: COMFORT AT THE IMPLANTABLE PROGRAMMABLE GENERATOR SITE (9 October, 2013)

  John McAuley, Y Aydin, CR Green, R van Gröningen
• 122: SUSAC SYNDROME IN THE ABSENCE OF ENCEPHALOPATHY AND NORMAL MRI (9 October, 2013)

  Christopher Owen, Venkat Garikipati, Nicolas Weir
• 123: A REVERSIBLE ENCEPHALOPATHY WITH ATAXIA AND UNUSUAL MRI ABNORMALITIES (9 October, 2013)

  Jay Panicker, Ivan Iniesta, Martin Wilson
• 124: EUNATRAEMIC HYPOKALAEMIC CENTRAL PONTINE MYELINOLYSIS IN AN ALCOHOLIC LADY WITH BULIMIA (9 October, 2013)

  Emily Pegg, Rebecca Exley, Shuja Punekar, Hedley Emsley
• 125: PRISM ADAPTATION IN PATIENTS WITH LESIONS TO THE INTRAPARIETAL CORTEX: DIFFERENTIAL EFFECTS ON VISUAL AND PROPRIOCEPTIVE COMPONENTS (9 October, 2013)

  Michael Hollifield, Janet Bultitude, Robert Rafal
• 126: HEAVY METAL TOXICITY: LESSONS FROM A CASE OF SIMULTANEOUS OCCUPATIONAL EXPOSURE TO MANGANESE AND MERCURY (9 October, 2013)

  Sam Shribman, Angharad Davis, Norbert Vella, Gavin Giovannoni
• 127: NEUROPHYSIOLOGICAL ASSESSMENT OF SPINAL FUNCTION IN SURGICAL TREATMENT OF PATIENTS WITH CERVICAL SPONDYLOGENIC MYELOPATHY (9 October, 2013)

  Albina Tretiakova
• 128: UNDERSTANDING THE TRIGEMINAL CERVICAL CONNECTIONS; AN OBSERVATION (9 October, 2013)

  Catherine Gillies, Alok Tyagi
• 129: INITIATION OF DIETARY INTERVENTION AFTER 20 YEARS OF UNTREATED PKU (9 October, 2013)

  Briony Waddell, Mohamed Anwar, Jonathon I O'Riordan
• 130: THE IMPACT OF ABUSE & OTHER ADVERSE EVENTS IN THE GENERAL NEUROLOGY CLINIC–FROM FREUD TO SAVILE? (9 October, 2013)

  Graham Warner
• 131: RARITIES IN NEUROLOGY: BLUE RUBBER BLEB NEVUS SYNDROME (9 October, 2013)

  Ray Wynford–Thomas, Ann Johnston, Shawn Halpin, Khalid Hamandi
• 132: TEN YEARS OF NEUROGENETIC REQUESTS: TO TEST OR NOT TO TEST? (9 October, 2013)

  Jason Appleton, David Nicholl, Piers Fulton, Fiona Macdonald
• 133: GLOBUS PALLIDUS HIGH–SIGNAL LESIONS: A PREDOMINANT MRI FINDING IN CHILDREN WITH NEUROFIBROMATOSIS TYPE 1 (9 October, 2013)

  Aravindhan Baheerathan
• 134: ATAXIA AND EPILEPSY DUE TO A RARE AUTOSOMAL MITOCHONDRIAL DISEASE (9 October, 2013)

  Bharath Kumar Cheripelli, Callum Duncan
• 135: AN UNUSUAL CASE OF PROGRESSIVE CEREBELLAR ATAXIA (9 October, 2013)

  Suresh Kumar Chhetri, Tahir Majeed, Jeremy Dick, AMR Taylor, John Ealing
• 136: MOLECULAR GENETIC STUDIES OF NEURODEGENERATIVE DISEASE (9 October, 2013)

  Tim Cooke, CB Carroll, JP Zajicek, S Ellard, KE Morrison
• 137: PROGRESSIVE COGNITIVE DIFFICULTIES IN ADULT PATIENTS WITH MITOCHONDRIAL DISEASE (9 October, 2013)

  Heather Moore, Thomas Kelly, Michael Trenell, Ian Deary, Douglass Turnbull, Grainne Gorman
• 138: A MUTATION IN THE DNMT1 GENE CAUSING AUTOSOMAL DOMINANT ATAXIA WITH DEAFNESS AND CATAPLEXY (9 October, 2013)

  Gosal David, Ealing John, Mignot Emmanuel
• 139: WEIGHT LOSS, ENCEPHALOPATHY, URINARY DIFFICULTIES AND NUMB FEET IN A NIGERIAN MAN (9 October, 2013)

  P McColgan, S Viegas, S Gandhi, F Sheikh, J Pinney, M Fontana, D Rowczenio, S Shah, Z Jaumuktane, J Holton, J Schott, D Werring, P Hawkins, MM Reilly
• 140: ADULT ONSET ALEXANDER DISEASE: A DIAGNOSIS TO CONSIDER IN LATE–ONSET SPORADIC SPINOCEREBELLAR ATAXIA (9 October, 2013)

  Vahini Paramesan, Andrew D MacKinnon, Salah Omer
• 141: A LATE ONSET ATAXIA WITH TELANGIECTASIA (9 October, 2013)

  Noor Sharrack, Laurence Newrick, Marios Hadjivassiliou
• 142: THE YIELD FROM TESTING VOLTAGE–GATED POTASSIUM CHANNEL ANTIBODIES IN PATIENTS WITH CRAMP (9 October, 2013)

  Sonam Ansel, Maria E Farrugia
• 143: CENTEROVIRUS ENCEPHALITIS COMPLICATING RITUXIMAB TREATMENT: A TREATABLE CONDITION (9 October, 2013)

  Jennifer Dineen, Shane Smyth
• 144: PARANEOPLASTIC LIMBIC ENCEPHALITIS AND LAMBERT EATON MYASTHENIA–AN IMMUNOLOGICAL PROFILE OF A NEW SYNDROME? (9 October, 2013)

  Seema Kalra, Paul Gozzard, Andre Leonard, Paul Maddison, Saiju Jacob
• 145: AUTOIMMUNE GABAB ANTIBODY ENCEPHALITIS ASSOCIATED WITH NON–MALIGNANT LUNG LESION (9 October, 2013)

  Barbara Wysota, Lara Teare, Abid Karim, Saiju Jacob
• 146: PERIPHERAL NERVE HYPEREXCITABILITY WITH ANTI–VGKC ANTIBODIES PRESENTING AS MUSICIAN'S DYSTONIA (9 October, 2013)

  Christopher Kobylecki, Andrew Marshall, Jon Sussman, Hisham Hamdalla
• 147: ANTI GLUTAMIC ACID DECARBOXYLASE ANTIBODY MEDIATED ENCEPHALOPATHY WHILE ON ETANERCEPT IN A PATIENT WITH MULTIPLE AUTOIMMUNE DISEASES (9 October, 2013)

  Niall MacDougall, Briony Waddell, Jonathan I O'Riordan
• 148: FACIOBRACHIAL DYSTONIC SEIZURES: TWO CASES ALIKE, BUT NOT THE SAME (9 October, 2013)

  Elizabeth Visser, Callum Duncan, John Reid
• 149: LOWER URINARY TRACT SYMPTOMS IN FUNCTIONAL MOVEMENT DISORDERS (9 October, 2013)

  Amit Batla, Jalesh Panicker, Mark Edwards, Maria Stamelou, Isabel Parees, Panagiotis Kasavetis, Kailash Bhatia
• 150: Δ9–TETRAHYDROCANNABINOL IS PROTECTIVE THROUGH PPARγ DEPENDENT MITOCHONDRIAL BIOGENESIS IN A CELL CULTURE MODEL OF PARKINSON'S DISEASE (9 October, 2013)

  Marie–Louise Zeissler, Jordan Eastwood, C Oliver Hanemann, John Zajicek, Camille Carroll
• 151: DOPAMINE TRANSPORTER (DAT) IMAGING CAN BE NORMAL WITH NEUROPATHOLOGICALLY CONFIRMED CORTIOBASAL DEGENERATION (9 October, 2013)

  Sangeeta Chaal, James Rowe
• 152: PISA SYNDROME IN PARKINSON'S DISEASE–A MOBILE OR FIXED DEFORMITY? (9 October, 2013)

  Karen Doherty, Indran Davagnanam, Sean Molloy, Laura Silveira–Moriyama, Andrew Lees
• 153: A CASE SUPPORTING THE ROLE OF THE CEREBELLUM IN DYSTONIA (9 October, 2013)

  Anisha Doshi, Jonathon Rohrer, Tom Warner
• 154: GREY MATTER AND CSF AMYLOID IN EARLY NON–DEMENTED PARKINSON'S DISEASE: THE INCIDENCE OF COGNITIVE IMPAIRMENT IN COHORTS WITH LONGITUDINAL EVALUATION IN PARKINSON'S DISEASE (ICICLE–PD) STUDY (9 October, 2013)

  Gordon W Duncan, Alison J Yarnall, Michael J Firbank, Roger A Barker, John T O'Brien, David J Burn
• 155: GREY MATTER CORRELATIONS OF COGNITIVE IMPAIRMENT IN EARLY PARKINSON'S DISEASE: THE INCIDENCE OF COGNITIVE IMPAIRMENT IN COHORTS WITH LONGITUDINAL EVALUATION–PARKINSON'S DISEASE (ICICLE–PD) STUDY (9 October, 2013)

  Gordon W Duncan, Michael J Firbank, Alison J Yarnall, Roger A Barker, John T O'Brien, David J Burn
• 156: CONGENITAL MUSCULAR TORTICOLLIS AND CERVICAL DYSTONIA (9 October, 2013)

  Venkat Garikipati, William Gibb
• 157: PHASE RESPONSE CURVES PROVIDE INSIGHT INTO THE PATHOPHYSIOLOGY OF TREMOR DISORDERS AND NOVEL POTENTIAL TREATMENT STRATEGIES (9 October, 2013)

  Tabish A Saifee, Mark J Edwards, Tom Gilbertson
• 158: DIRECT CURRENT STIMULATION AND TRAINING IN PARKINSON'S DISEASE: BETTER OUTCOMES IN MORE ADVANCED DISEASE (9 October, 2013)

  Diego Kaski, Raul Dominguez, John Allum, Adolfo Bronstein
• 159: GENOTYPE SPECIFIC CEREBELLAR INVOLVEMENT IN DYT1 AND DYT6 DYSTONIA? (9 October, 2013)

  Anna Sadnicka, James Teo, Maja Kojovic, Panagiotis Kassavetis, Tabish Saifee, Parees Isabel, Petra Schwingenschuh, John Rothwell, Kailash Bhatia, Mark Edwards
• 160: FAMILY HISTORY IN YOUNG ONSET PARKINSON'S DISEASE (9 October, 2013)

  Naveed Malek, Nin Bajaj, Roger Barker, Yoav Ben–Shlomo, David Burn, Thomas Foltynie, Huw Morris, Nigel Williams, Nicholas Wood, Donald Grosset
• 161: TRACKING PARKINSON'S (THE PROBAND STUDY)–INTERIM REPORT FROM THE FIRST 1000 CASES (9 October, 2013)

  Donald Grosset, Naveed Malek, Nin Bajaj, Roger Barker, David Burn, Yoav Ben–Shlomo, Tom Foltynie, Huw Morris, Nigel Williams, Nicholas Wood
• 162: USING ‘DEAD OR DEPENDENT’ AS AN OUTCOME MEASURE IN PARKINSON'S DISEASE CLINICAL TRIALS (9 October, 2013)

  David McGhee, Alexander Parker, Shona Fielding, Carl Counsell
• 163: WHICH CLINICAL MEASURES ARE MOST APPROPRIATE FOR MEASURING DISEASE PROGRESSION IN PARKINSON'S DISEASE? (9 October, 2013)

  David McGhee, Alexander Parker, Shona Fielding, Carl Counsell
• 164: MONOTHERAPY CHOICES IN EARLY PARKINSON'S DISEASE (9 October, 2013)

  R Morrison, EJ Newman, DG Grosset
• 165: IMPROVEMENT OF PARKINSONIAN SYMPTOMS WITH SPINAL CORD STIMULATION: CONSEQUENCE OR COINCIDENCE? (9 October, 2013)

  Fardad Soltani, Abdul Lalkhen
• 166: ARE THERE NON–MOTOR SYMPTOMS SPECIFIC TO PARKINSON'S DISEASE? (9 October, 2013)

  Malcolm Steiger, Sui Wong, Joanne Crossley, Nick Fletcher, Gus Baker, Udo Wieshmann
• 167: LONG TERM USAGE OF ARIPIPRAZOLE IN TOURETTE SYNDROME (9 October, 2013)

  Arron Cook, Jeremy S Stern, David Williams, Kathryn Grabecki, Helen Simmons, Mary M Robertston
• 168: TIC ATTACKS IN TOURETTE SYNDROME (9 October, 2013)

  Nathan J Collicott, Jeremy S Stern, David Williams, Kathryn Grabecki, Helen Simmons, Mary M Robertson
• 169: CLINICAL PHENOTYPE–SPECIFIC DIFFERENCES IN CEREBRAL HAEMODYNAMICS IN IDIOPATHIC PARKINSON'S DISEASE (9 October, 2013)

  Sarah Al–Bachari, Laura Parkes, Rishma Vidyasagar, Martha Hanby, Vivek Tharaken, Iracema Leroi, Hedley Emsley
• 170: USING ROUTINE POINT–OF–CARE DATA FOR RESEARCH: THE EAST LONDON MULTIPLE SCLEROSIS COHORT (9 October, 2013)

  Christo Albor, Oliver Richards, Sreeram Ramagopalan, Kambiz Boomla, Klaus Schmierer
• 171: FIRST USE OF ALEMTUZUMAB IN BALO CONCENTRIC SCLEROSIS: A CASE REPORT (9 October, 2013)

  J William L Brown, Joanne L Jones, Alasdair J Coles
• 172: PATTERNS OF COGNITIVE DYSFUNCTION IN PROGRESSIVE MULTIPLE SCLEROSIS (9 October, 2013)

  Peter Connick, Siddharthan Chandran, Thomas Bak
• 173: THINK OUTSIDE THE BOX, COLLAPSE THE BOX, AND TAKE A SHARP KNIFE TO IT! (9 October, 2013)

  Ruth Dobson, Annabelle McMillan, Karen Kung, Maria Thom, Angharad Davis, Robert Simister, Gavin Giovannoni, Sharmilee Gnanapavan
• 174: A DECADE OF DATA FOR THE UK MULTIPLE SCLEROSIS RISK–SHARING SCHEME (9 October, 2013)

  Martin Duddy, Jackie Palace
• 175: HOW OFTEN DOES RESPIRATORY FAILURE OCCUR IN NEUROMYELITIS OPTICA? (9 October, 2013)

  Liene Elsone, Yee Yen Goh, Rosie Trafford, Kerry Mutch, Anu Jacob
• 176: NEUTRALISING ANTIBODIES TO INTERFERON–BETA PREDICT CONVERSION TO SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS IN PATIENTS WITH MULTIPLE SCLEROSIS (9 October, 2013)

  Arie Gafson, Viki Worthington, Neghat Lakdawala, Gavin Giovannoni, Rachel Farrell
• 177: ACUPUNCTURE IS AN EFFECTIVE TREATMENT FOR PAIN AND OTHER MS SYMPTOMS (9 October, 2013)

  JW Kerr Grieve, Shona Flucker, Jonathan O'Riordan
• 178: A SERVICE DEVELOPMENT AUDIT OF FAMPRIDINE USE IN MS (9 October, 2013)

  Shahrzad Hadavi, Gavin Giovannoni, Ruth Dobson
• 179:

  EFFICACY AND SAFETY OF NATALIZUMAB TREATMENT FOR RELAPSING–REMITTING MULTIPLE SCLEROSIS: INTERIM RESULTS OF THE TYSABRI^® OBSERVATIONAL PROGRAMME IN THE UK

  (9 October, 2013)

  Jerome Hanna, Jan Paul Rosen, Caroline Smethurst
• 180: PROBING THE POTENTIAL FOR FUNCTIONAL RECOVERY IN PATIENTS WITH NEUROMYELITIS OPTICA USING VISUOMOTOR PRACTICE (9 October, 2013)

  Bethan E John, Sebastian Luppe, Hannah Khirwadkar, Michelle Smalley, Margaret Hourihan, Neil Robertson, Valentina Tomassini
• 181: DOES JCV ANTIBODY POSITIVITY ENCOURAGE CESSATION OF NATALIZUMAB THERAPY IN MULTIPLE SCLEROSIS? (9 October, 2013)

  Roisin Lonergan, Katie Kinsella, Siobhan Kelly, Marguerite Duggan, Jacqueline Scott, Killian O'Rourke, Timothy Lynch, Michael Hutchinson, Niall Tubridy, Christopher McGuigan
• 182: CANNABINOID USE IN PROGRESSIVE INFLAMMATORY BRAIN DISEASE (CUPID) MRI SUB–STUDY (9 October, 2013)

  Shahrukh Mallik, Susan Ball, Catherine Dalton, David MacManus, Daniel Tozer, David Miller, John Zajicek
• 183: REGIONAL PATTERNS OF GREY MATTER ATROPHY AND MAGNETISATION TRANSFER RATIO ABNORMALITIES IN MULTIPLE SCLEROSIS CLINICAL SUBGROUPS (9 October, 2013)

  Shahrukh Mallik, Nils Muhlert, Rebecca Samson, Claudia Wheeler–Kingshott, David Miller, Declan Chard
• 184: THE BRADYKINESIA–AKINESIA INCOORDINATION TEST: A SIMPLE OBJECTIVE TEST IN MULTIPLE SCLEROSIS (9 October, 2013)

  Shahrzad Hadavi, Sam Shribman, Anna Nagy, Shami Acharya, Julian Fearnley, Ruth Dobson, Andrew Lees, Gavin Giovannoni, Alastair Noyce
• 185: MULTIPLE SCLEROSIS AND THE IRANIAN REVOLUTION (9 October, 2013)

  Julia Pakpoor, Sreeram Ramagopalan
• 186: IMPROVING THE MODEL FOR THE UK MS DISEASE MODIFYING TREATMENT RISK SHARING SCHEME ANALYSIS: A NEW NATURAL HISTORY DATASET (9 October, 2013)

  Jacqueline Palace, Thomas Bregenzer, Helen Tremlett, Martin Duddy, Mike Boggild, Feng Zhu, Joel Oger, Charles Dobson
• 187: PROGRESSIVE NEUROLOGICAL DEFICIT FROM A SOLITARY SPATIALLY ISOLATED DEMYELINATING LESION: SOLITARY SCLEROSIS–THE FIRST SERIES FROM THE UK (9 October, 2013)

  Devipriya Rathnasabapathi, Liene Elsone, Anu Jacob
• 188: LOBAR DISTRIBUTION OF CORTICAL GREY MATTER LESIONS IN MULTIPLE SCLEROSIS CLINICAL SUBGROUPS (9 October, 2013)

  Varun Sethi, Tarek A Yousry, Nils Muhlert, Daniel Tozer, Maria Ron, Xavier Golay, Claudia Wheeler–Kingshott, David H Miller, Declan T Chard
• 189: A CASE OF NEUROMYELITIS OPTICA WITH LOCKED–IN SYNDROME (9 October, 2013)

  Nazar Sharaf, David Gosal
• 190: BASELINE RESPONSES OF MULTIPLE SCLEROSIS PATIENTS PARTICIPATING IN THE PROMS SURVEY: IMPACT OF DISEASE–MODIFYING THERAPIES AND SUPPORT SERVICES ON PATIENT–REPORTED OUTCOMES (9 October, 2013)

  Simon Shields, Laura Parkes
• 191: MOST NEUROLOGISTS IN SCOTLAND DO NOT USE THE MCDONALD 2010 CRITERIA TO DIAGNOSE MULTIPLE SCLEROSIS (9 October, 2013)

  Ruby Lumley, Richard Davenport, Anna Williams
• 192: USE OF SERVICES FOR MULTIPLE SCLEROSIS PATIENTS ACCORDING TO EDSS (9 October, 2013)

  Mark Willis, Katherine Harding, Neil Robertson
• 193: OPTIC PERINEURITIS: UNCOMMON PRESENTATION OF MORE COMMON DISEASES (9 October, 2013)

  Syed Zaidi
• 194: PATIENTS WITH AN ACUTE MULTIPLE SCLEROSIS RELAPSE: A HIGH RISK GROUP FOR OSTEOPENIA AND OSTEOPOROSIS (9 October, 2013)

  Olwen Murphy, Michael S Zandi, Nitzan Lindenberg, Elaine Murphy, Jeremy Chataway
• 195: PAIN IN NEUROMYELITIS OPTICA IS AN UNDER–RECOGNISED BUT DISABLING SYMPTOM (9 October, 2013)

  Sizheng Zhao, Kerry Mutch, Liene Elsone, Turo Nurmikko, Anu Jacob
• 196: SEASONAL VARIATION, SUB–TYPE AND PRODROMAL ILLNESSES IN GUILLAIN–BARRE SYNDROME (9 October, 2013)

  Susannah Brain, Alastair Webb, Marc Zentar, Martin R Turner
• 197: WHEN YOUR HEART IS AFLUTTER AND YOU'RE WEAK AT THE KNEES: A CASE REPORT (9 October, 2013)

  Amy Davidson, Cheryl Longman, Maria Farrugia
• 198: SLOWLY PROGRESSIVE UPPER LIMB WEAKNESS: TWO CASES OF HIRAYAMA DISEASE AND REVIEW OF LITERATURE (9 October, 2013)

  Mona Ghadiri–Sani, Charlotte Dougan, Bryan Lecky
• 199: EVALUATION OF FUNCTIONAL OUTCOME MEASURES AS A SURROGATE MARKER OF DISEASE SEVERITY IN PATIENTS WITH MITOCHONDRIAL DISEASE (9 October, 2013)

  Jane Newman, Brook Galna, Djordje Jakovljevic, Matthew Bates, Andrew Schaefer, Robert McFarland, Douglass Turnbull, Michael Trenell, Lynn Rochester, Grainne Gorman
• 200: A STUDY OF THE CLINICAL UTILIZATION OF SURAL NERVE BIOPSY IN NEUROLOGICAL PRACTICE OVER A SEVEN YEAR PERIOD IN GREATER MANCHESTER (9 October, 2013)

  Sidra Khan, Vino Srirathan, David Yunus Gosal
• 201: DIAGNOSIS OF SMALL FIBRE NEUROPATHIES–THE NEED TO GET THE BASICS RIGHT (9 October, 2013)

  Michael Johnston, David Yunus Gosal
• 202: BENT DOUBLE: CONCOMITANT CAUSES OF CAMPTOCORMIA (9 October, 2013)

  Ingrid Hoeritzauer, John McKinley, Kiang Pang, Seamus Kearney
• 203: DISTAL SPINAL MUSCULAR ATROPHY WITH VOCAL PARESIS: FROM THE WELSH CHOIR TO GENES (9 October, 2013)

  Gillian Ingram, Katy Barwick, Meriel McEntagart, Andrew Crosby, Louise Hartley, Gareth Llewelyn, Huw Morris
• 204: THE EFFECTS OF HIGH INTENSITY INTERVAL TRAINING ON CLINICAL SYMPTOMS AND FUNCTIONAL CAPACITY IN ADULTS WITH NEUROMUSCULAR DISEASE (9 October, 2013)

  Katherine Jones, Roger Whittaker, James Miller, Djordje Jakovljevic, Doug Turnbull, Grainne Gorman
• 205: CAMPTOCORMIA AS A PRESENTATION OF POLYMYOSITIS (9 October, 2013)

  Nazia Karsan, John O'Dwyer, Ali Al–Memar
• 206: ELECTROLYTE IMBALANCE TRIGGERING RELAPSE OF INFLAMMATORY NEUROPATHY (9 October, 2013)

  A Keshavan, S Gandhi, MP Lunn, MM Reilly
• 207: WASTED AND WEAK ARM IN A YOUNG MAN (9 October, 2013)

  Yi Shiau Ng, Mireia Moragas, Siddharthan Chandran
• 208: EFFECT OF LIPID PROFILE ON PROGNOSIS IN THE PATIENTS WITH AMYOTROPHIC LATERAL SCLEROSIS (9 October, 2013)

  Muhammad Rafiq, Ellen Lee, Michael Bradburn
• 209: A NOVEL TAUOPATHY PRESENTING WITH A MOTOR NEURONE DISEASE PHENOTYPE (9 October, 2013)

  Emma Tallantyre, Adrian Wills, Tamas Revesz, James Lowe
• 210: REVIEW OF NEUROPHYSIOLOGY DATA IN PATIENTS REFERRED AS WINGED SCAPULA (9 October, 2013)

  Maruthi Ravi Vinjam, Ibrahim Ali, Taysir Bukhari
• 211: STATINS CAN CAUSE MYASTHENIA GRAVIS: FACT OR FICTION? (9 October, 2013)

  Jonathan Virgo, Sui Wong, Khadija Rantell, Gordon Plant
• 212: SENSORY NEURONOPATHY; A CASE REPORT AND A REVIEW OF THE ROLE OF GANGLION NERVE BIOPSY IN DIAGNOSIS (9 October, 2013)

  Briony Waddell, Simon Farmer, Mike Lunn, Jonathon I O'Riordan
• 213: FOSMN: FACIAL ONSET SENSORY MOTOR NEURONOPATHY. A ‘BENIGN’ DIFFERENTIAL DIAGNOSIS TO BULBAR ONSET MOTOR NEURON DISEASE. THE FIRST COHORT FROM THE UK (9 October, 2013)

  Besa Ziso, Tim Williams, Jon Walters, Stephan Jaiser, Udo Wieshmann, Anu Jacob
• 214: A FATAL CASE OF ‘PRIMARY’ HEADACHE (9 October, 2013)

  Rejith Dayanandan, Dorothea Bindman, Suresh Kumar Chhetri, Joseph Jacob, Sachin Mathur, Roger John Mills
• 215: PRIMARY CNS LYMPHOMA MASQUERADING AS TUMEFACTIVE DEMYELINATION (9 October, 2013)

  Shan Ellawela, Robin Joseph, Andres Kulla, Colin O'Leary
• 216: PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA INTERACTING WITH A PRE–EXISTING CEREBRAL AMYLOID ANGIOPATHY DEMONSTRATED AS AN OLD RIGHT FRONTAL HAEMORRHAGE ON IMAGING (9 October, 2013)

  Othman Kirresh
• 217: A STROKE MIMIC; FOCAL NEUROLOGICAL DEFICITS IN BENIGN HEREDITARY CHOREA? (9 October, 2013)

  Katie Maw, JA Johnston, C Rowntree, A Kalhan
• 218: CEREBRAL WHITE MATTER DISEASE IN PATIENTS WITH MALIGNANCY: PML VERSUS TOXIC LEUCOENCEPHALOPATHY DUE TO CHEMOTHERAPY (9 October, 2013)

  Mary Aspinall, Piyali Pal, Rajiv Mohanraj
• 219: A RARE CAUSE OF THE CAVERNOUS SINUS SYNDROME AND AN OLD CLINICAL LESSON RELEARNT (9 October, 2013)

  Yi Shiau Ng, Richard Davenport, Angus Broom
• 220: A CJD MIMIC; ‘FEEDING ICE–CREAM TO HER CATS’ (9 October, 2013)

  Cherry Shute, Ann Johnston, Jim Neal, Philip Smith
• 221: SODIUM OXYBATE AS A TREATMENT FOR DBS–RESISTANT, ALCOHOL–RESPONSIVE POST–ANOXIC MYOCLONUS (9 October, 2013) Free

  Joshua Kahan, Zinovia Kefalopoulou, James Gratwicke, Iciar Aviles-Olmos, Ludvic Zrinzo, Marwan Hariz, Patricia Limousin, Tom Foltynie